| Adrenal Medulla Neoplasm studied in …STUDIED_INderived127 of 127show fewer |
|---|
| → studied in | NCT00004847Phase 1 · recruiting Diagnosis of Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07743138Phase 2 · not yet recruiting STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL) · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04394858Phase 2 · active not recruiting Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02402244recruiting Project: Every Child for Younger Patients With Cancer · condition mapped ONTOLOGY_EXACT · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03206060Phase 2 · recruiting Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06427798Phase 1/Phase 2 · recruiting Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06377033NA · recruiting Using the EHR to Advance Genomic Medicine Across a Diverse Health System · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015844available A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714551Phase 2 · not yet recruiting Zanzalintinib in Unresectable and Progressive MPGGs · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02721732Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07538791not yet recruiting Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT) · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04573816completed Development of a Tele-monitoring Program for Patients Undergoing Surgery for Pheochromocytoma and / or Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07680205Phase 2 · recruiting An Experimental Study of Belzutifan Impact on Catecholamine Metabolism · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07661420Phase 1 · not yet recruiting 211At-MABG in Adults With Advanced Neuroendocrine Cancers · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541720early Phase 1 · active not recruiting 18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06607692Phase 1/Phase 2 · recruiting Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107289Phase 2 · recruiting Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05636618Phase 1/Phase 2 · recruiting Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583528active not recruiting DOTATOC PET/CT for Imaging NET Patients · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00669266recruiting Adrenal Tumors - Pathogenesis and Therapy · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01163383available 131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07516275not yet recruiting Prospective Cohort Study of Pheochromocytoma/Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119024Phase 1 · recruiting Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03839498Phase 2 · active not recruiting Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03946527Phase 2 · active not recruiting LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05636540early Phase 1 · recruiting In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03165721Phase 2 · terminated A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04711135Phase 2 · active not recruiting Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01022515NA · completed Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04187404Phase 1/Phase 2 · terminated A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06573723recruiting Institutional Registry of Rare Diseases · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07339241completed Abdominal Circumference as a Predictor of Operative Time in Retroperitoneal Adrenalectomy for Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01850888NA · completed MIBG for Refractory Neuroblastoma and Pheochromocytoma · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03160274recruiting Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07200245not yet recruiting Cardiovascular Complications After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07195500recruiting Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06813742recruiting 18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02302833Phase 2 · completed Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04400474Phase 2 · completed Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05702944Phase 4 · recruiting The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05944237Phase 1/Phase 2 · recruiting HTL0039732 in Participants With Advanced Solid Tumours · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06429397Phase 2 · not yet recruiting Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06062082completed Intraoperative Hemodynamic Instability During Unilateral Adrenalectomy for Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06233903Phase 2 · withdrawn 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04028479completed The Registry of Oncology Outcomes Associated With Testing and Treatment · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03649438no longer available 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06444607recruiting Hereditary Pheochromocytoma Assessment of Tumour Immunologies · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06669481completed Correlation Between Preoperative Images of PPGL and Intraoperative Hemodynamics · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00843037Phase 2 · completed Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01379898Phase 4 · completed Phenoxybenzamine Versus Doxazosin in PCC Patients · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00655655Phase 1 · completed Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05053685completed Metanephrines in Obstructive Sleep Apnoea · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06045260Phase 2 · recruiting "Receptor Radionuclide Therapy With 177Lu-DOTATOC · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06523582recruiting Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04860700Phase 2 · completed The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06440122unknown The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs) · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04605848NA · terminated Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue (MICROBAT) · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00970970completed Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05446779active not recruiting Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06229405unknown Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05069220early Phase 1 · recruiting 18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03008369Phase 2 · completed Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03176693Phase 3 · completed Preoperative Alpha Blockade for Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05456997terminated Metabolic Myopathy in Endocrinopathy · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06037135NA · completed Dexmedetomidine Infusion During Laparoscopic Adrenalectomy · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06050057unknown Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06015061unknown Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01838187no longer available Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05158712unknown Genetic Factors and Pheochromocytomas in Neoplasia Type 2 · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05948137terminated F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03986593NA · terminated Cryoablation of Bone Metastases From Endocrine Tumors · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05885399Phase 2 · unknown The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05885386Phase 2 · unknown A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05883085Phase 2 · unknown A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05858177Phase 2 · completed The Efficacy and Safety of Temozolomide in Patients With MPPGL · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04788927not yet recruiting Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05803330NA · completed Study of Alpha-blockers Alone During Preoperative Preparation in Patients With Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02186678NA · completed Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04276597Phase 2 · withdrawn Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01590680available Expanded Access Protocol Using 131I-MIBG · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02431715no longer available 18F-FDOPA PET in Neuroendocrine Tumours · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05451134unknown Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01949714completed Effect of Chronic Catecholamine Overproduction on Brown Adipose Tissue · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04890444unknown China Adrenal Disease Registry · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05082311completed Cardiac and Vascular Changes in Pheochromocytoma and Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320589Phase 2 · completed the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04557072completed Selective Versus Nonselective Alpha-blockade Prior to Pheochromocytoma Resection - Systematic Review and Meta-analysis · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03923257Phase 1/Phase 2 · withdrawn Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04891081unknown Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01967576Phase 2 · completed Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04566406completed Pheochromocytoma and Hemodynamic Instability · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106843Phase 2 · withdrawn Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03344016NA · recruiting Multicenter Pheochromocytoma and Paraganglioma Evaluation · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01377532approved for marketing Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01635907Phase 2 · completed Dovitinib in Neuroendocrine Tumors · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03474237enrolling by invitation A Prospective Cohort Study for Patients With Adrenal Diseases · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00874614Phase 2 · unknown A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04071561completed Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126412Phase 3 · completed Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02961491approved for marketing Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01413503Phase 2 · completed A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02831179Phase 1 · withdrawn Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01340794Phase 2 · terminated Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028106Phase 2 · completed 131MIBG to Treat Malignant Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03158870unknown Surgeon-Anesthesiologist Collaboration · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02618694NA · completed Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458952Phase 1/Phase 2 · completed Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049023Phase 1 · completed Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01155258Phase 1 · completed Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00923481Phase 2 · completed A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00188019NA · completed Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01152827Phase 2 · completed RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002641Phase 3 · completed Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002947Phase 1 · terminated Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01425710completed Non-invasive Evaluation of Fluid Status and Cardiac Output During Operative Treatment of Pheochromcytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01959711Phase 4 · completed Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002608Phase 2 · completed Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00911729terminated Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002764Phase 3 · completed Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00466856Phase 2 · terminated Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00339131Phase 1 · completed ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01373736Phase 3 · unknown 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00590096completed I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001147completed Blood Sampling for Neurochemical and Genetic Testing · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001229completed Diagnosis and Treatment of Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |